Varian Medical Systems, Inc. VAR
Set alert
— — —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 16.26B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 29.66
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 3, 2021
- 50-d avg
- 176.57
- 200-d avg
- 174.89
- 1y target
- 177.67
Analyst view
Consensus: hold
Hold
Price target (mean) 177.67
- Target (low)
- 177.50
- Target (mean)
- 177.67
- Target (high)
- 178.00
Ratings (0m) 8 2 buy · 6 hold · 0 sell
- Strong buy2
- Buy0
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 5
- 2 months ago 6
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.15 | 1.02 – 1.28 | 0.85 | +35.3% | 862.15M | +8.5% | 4 |
| Next quarter | 1.22 | 1.02 – 1.33 | 0.78 | +56.4% | 841.37M | 0.0% | 3 |
| Current year | 5.12 | 4.43 – 5.83 | 3.91 | +30.9% | 3.53B | +11.5% | 6 |
| Next year | 5.97 | 4.78 – 6.53 | 5.12 | +16.6% | 3.91B | +10.7% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 7, 2020 | Jefferies | Downgrade | Buy | Hold |
| Oct 28, 2020 | Baird | Downgrade | Outperform | Neutral |
| Aug 11, 2020 | BTIG | Downgrade | Buy | Neutral |
| Aug 3, 2020 | Jefferies | Maintained | — | Buy |
| Aug 3, 2020 | Evercore ISI Group | Upgrade | Underperform | In-Line |
| Jul 27, 2020 | Piper Sandler | Maintained | — | Overweight |
| May 5, 2020 | UBS | Maintained | — | Buy |
| Apr 17, 2020 | JP Morgan | Maintained | — | Underweight |
| Apr 9, 2020 | Evercore ISI Group | Downgrade | Outperform | Underperform |
| Apr 8, 2020 | Piper Sandler | Initiated | — | Overweight |
| Apr 1, 2020 | Goldman Sachs | Downgrade | Buy | Neutral |
| Mar 10, 2020 | Baird | Maintained | — | Outperform |
| Mar 10, 2020 | UBS | Maintained | — | Buy |
| Feb 13, 2020 | Goldman Sachs | Initiated | — | Buy |
| Jan 30, 2020 | Baird | Maintained | — | Outperform |
| Jan 2, 2020 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Dec 4, 2019 | UBS | Maintained | — | Buy |
| Oct 14, 2019 | BTIG | Upgrade | Neutral | Buy |
| Sep 12, 2019 | Evercore ISI Group | Upgrade | Underperform | In-Line |
| May 2, 2019 | Citigroup | Maintained | Buy | Buy |
| Apr 25, 2019 | UBS | Maintained | Buy | Buy |
| Mar 22, 2019 | Baird | Upgrade | Neutral | Outperform |
| Jan 4, 2019 | Goldman Sachs | Upgrade | Neutral | Buy |
| Jan 2, 2019 | Citigroup | Maintained | Buy | Buy |
| Nov 28, 2018 | UBS | Initiated | — | Buy |
| Nov 1, 2018 | Citigroup | Maintained | Buy | Buy |
| Oct 31, 2018 | Citigroup | Maintained | Buy | Buy |
| Oct 24, 2018 | JP Morgan | Maintained | Underweight | Underweight |
| Jan 25, 2018 | JP Morgan | Maintained | Neutral | Neutral |
| Jan 25, 2018 | Citigroup | Maintained | Neutral | Buy |